Several of the world’s most influential tech billionaires are now major backers of longevity research, pouring money into labs and biotech start-ups working to slow, halt, or even reverse aspects of a ...
Living to 150 is not science fiction according to chief technology officer Lyu Qinghua of Lonvi Biosciences, one of many Chinese companies working on anti-ageing treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback